newsfilter
← Latest News
Business Wire·

Assertio Announces Agreement to be Acquired by Garda Therapeutics

All-Cash Tender Offer of $18 per share – or $125.1 Million – Plus Contingent Value Right Tender Offer Price Represents 34.6% Premium to Unaffected Price and 46.6% Premium to Unaffected 30-day Volume-Weighted Average